发明名称 |
Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors |
摘要 |
The disclosure provides methods and compositions for treating a vascular, autoimmune, and/or inflammatory disease, or a condition associated therewith, with a dose of an inosine monophosphate dehydrogenase (IMPDH) inhibitor effective to treat the vascular, autoimmune and/or inflammatory disease, or associated condition but that does not produce immunosuppression sufficient to reduce the risk of allograft rejection. These lower doses of the immunosuppressant avoid the adverse consequences of severe immunosuppression while providing effective treatment of the vascular, autoimmune and/or inflammatory disease. |
申请公布号 |
US8957071(B2) |
申请公布日期 |
2015.02.17 |
申请号 |
US200812115464 |
申请日期 |
2008.05.05 |
申请人 |
Aspreva Pharmaceuticals S.A.;Aspreva Pharmaceuticals Corp. |
发明人 |
Glickman Richard;Hayden Michael R.;Hall Noel |
分类号 |
A61K31/535;A61K31/365;A61K31/343;A61K31/5377 |
主分类号 |
A61K31/535 |
代理机构 |
COH IP Law |
代理人 |
COH IP Law |
主权项 |
1. A method of treating atherosclerosis associated with a vascular, autoimmune and/or inflammatory disease, comprising administering to a human subject in need thereof an effective amount of mycophenolate mofetil (MMF), wherein the amount administered is less than 0.5 g/day. |
地址 |
Neuchatel CH |